Cytological grading of CA breast on FNAC and its correlation with histological grading. Correlation of HER2 / (Cerb B2) grading on IHC with results of FISH on 2+ positive cases of infiltrating carcinoma. – Dr. Sumedha Kotwal

Correlation of HER2 / (Cerb B2) grading on IHC with results of FISH on 2+ positive cases of infiltrating carcinoma. – Dr. Sumedha Kotwal

Phase III multinational multicentric randomized trials of hematopoetic factors in metastatic carcinoma breast. – Dr. Meenu Walia

Phase III multinational multicentric randomized trials of newer supportive therapies to prevent oral ulcers in patients undergoing chemotherapy. –  Dr. Meenu Walia

Phase II multinational multicentric trials of lepatanib in advanced carcinoma cervix. – Dr. Praveen Bansal

A randomized active control double blind, double dummy parallel group multinational study to assess the efficacy, tolerability and safety of newer anti-emetics Granisetron Transdermal Delivery System (GTDS) in Chemotherapy-induced Nausea and Vomiting (CINU) associated with the administration of moderately of highly emetogenic multiday chemotherapy. – Dr. Meenu Walia

Post marketing surveillance study of GnRH agonists in the treatment of advanced prostate cancer (Phase IV Study). – Dr. Meenu Walia
 

Efficacy and safety of XMO1 compared to placebo in patients with solid tumors or non-myeloid haematological tumours receiving non-platinum chemotherapy A multinational, multi-center, randomized, placebo-controlled double blind parallel group phase - III study. – Dr. Meenu Walia

Role of intensity modulated radiation in head and neck cancers - Dharamshila's experience. – Dr. Sandeep Agarwal

Evaluation of 2 DG as a radio modifier in treatment of glioblastoma multiforme. – Dr. Dinesh
 

Evaluation of efficacy and tolerability of capecitabine as a radio sensitizer in squamous cell carcinoma of head and neck. – Dr. Dinesh
 

Optimizing cancer radiotherapy with 2 DG dose escalation studies in patients with GBM. – Dr. Dinesh
 

Airway assessment and management in head and neck cancer patients. – Dr. Neha
 

Molecular analysis of FHIT gene and P16 and their association with HPV in Indian head and neck carcinoma patients. – Dr. Pawan
 

Analysis of genetic polymorpheris of P73 and P53 and the risk of cancers in Indian patients. – Dr. Pawan
 

Study of P53 mutations identification of hyploid sub and type of P53 in sporadic breast cancers. – Dr. Pawan
 

Molecular study of candidate genes on chromosome 16 in sporadic breast cancers. – Dr. Pawan
 

Study of BRCA-1 and BRCA-2 genes expression in human breast cancer cells.
 

Transcription factors AP-1 and NF-kB in breast carcinomas.
 

Methylation and expression of FHIT gene in Indian female breast cancer patients. 
 

An open label multicentric study to assess the efficacy and safety of recombinant human granulocyte colony stimulating factor (filgratism) injection in patients undergoing myelosuppressive chemotherapy. – Dr. Meenu Walia and Dr. Praveen Bansal
 

An open label multicentric study to assess the efficacy and safety of pegylated form of recombinant human granulocyte colony stimulating factor (pegfilgratism) injection in patients undergoing myelosuppressive chemotherapy. – Dr. Meenu Walia and Dr. Praveen Bansal
 

Phase ½ modified dose escalation, open label trial to detemnie the therapeutic effect and safety of INCB007839 combined with trastuzumab in patients with previously untreated HER2 positive metastatic breast cancer. – Dr. Meenu Walia
 

Phase III randomized, double-blind, active controlled, parallel-group study, conducted under in-house blinding conditions, to examine the safety, tolerability and efficacy of single dose of intravenous MK-0517 for the prevention of CINV associated with cisplatin chemotherapy. – Dr. Meenu Walia